Molecular Neurosurgery with Targeted Toxins - Image 1

£88.21

Humana Molecular Neurosurgery with Targeted Toxins

Name: Molecular Neurosurgery with Targeted Toxins
Brand: Humana
Price: 88.21 GBP
Availability: InStock

Neurology & Clinical Neurophysiology

This is the most expensive it has ever been. Walk away.

£88 today · previous high £88 · all-time low £88

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 62 days • 1 price levels

Days at Price

Price Analysis

Most common price: £88 (62 days, 100.0%)

Price range: £88 - £88

Price levels: 1 different prices over 62 days

Description

Pioneers and leading researchers explain the theory and techniques of using targeted toxins experimentally. The highly successful use of the 192 IgG-saporin and ME20.4-saporin immunotoxins to lesion the cholinergic basal forebrain in order to model the behavior, anatomy, physiology, and pharmacology of Alzheimer's disease in animals is treated in detail to give a potential user the knowledge to comfortably use the techniques involved. The uses of important new lesioning agents such as anti-DBH-saporin immunotoxin to make remarkably selective lesions of catecholaminergic neurons, hypocretin-saporin that can produce narcoleptic animals, and other saporin conjugates, such as neuropeptide-saporin conjugates for pain research and cholera toxin B chain-saporin to produce a model of CNS demyelination are explained by experts in the field. Review "...a good purchase for most neuroscience and neurology libraries." - Doody's Health Science Book Review Journal From the Back Cover The use of targeted cytotoxins to make highly selective neural lesions for both experimental and clinical purposes has already provided important animal models for diseases such as Alzheimer's, and holds great promise for research and clinical application to pain. In Molecular Neurosurgery With Targeted Toxins, pioneers in the field describe their hands-on experience with the experimental use of these toxins. The authors focus on the highly successful use of the immunotoxins, 192 IgG-saporin and ME20.4-saporin, to lesion the cholinergic basal forebrain in order to model the behavior, anatomy, physiology, and pharmacology of Alzheimer's disease in animals. Also discussed are the uses of anti-DBH-saporin immunotoxin to make remarkably selective lesions of catecholaminergic neurons, hypocretin-saporin that can produce narcoleptic animals, and other saporin conjugates, such as neuropeptide-saporin conjugates for pain research and cholera toxin B chain-saporin to produce a model of central nervous system demyelination. Overview perspectives and, in some cases, more practical details are provided that allow the reader to appreciate exactly what is involved in using these agents. Both practical and theoretical, Molecular Neurosurgery With Targeted Toxins provides readers with not only the background to understand these techniques, but also numerous real-life examples that can be readily adapted to new purposes and an ever-increasing number of new targeted toxins.

Product Specifications

Brand: Humana
Format: paperback
ASIN: 1617374202
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain: Amazon UK
Release Date: 16 December 2010
Listed Since: 11 July 2010

Barcode

No barcode data available

Humana Molecular Neurosurgery with Targeted Toxins

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Experimental Neurosurgery in Animal Models: 116 (Neuromethods, 116)

Neuroprotection Methods and Protocols: 399 (Methods in Molecular Biology, 399)

Molecular Aspects of Botulinum Neurotoxin: 4 (Current Topics in Neurotoxicity, 4)

Molecular Aspects of Botulinum Neurotoxin: 4 (Current Topics in Neurotoxicity, 4)

Molecular Neurobiological Techniques: 16 (Neuromethods, 16)

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Immunosuppressant Analogs in Neuroprotection

Botulinum Neurotoxins: 364 (Current Topics in Microbiology and Immunology, 364)

Electroporation Methods in Neuroscience: 102 (Neuromethods, 102)

Molecular Neurobiological Techniques: 16 (Neuromethods, 16)

Neuroprotective Signal Transduction (Contemporary Neuroscience)

Apoptosis Techniques and Protocols: 37 (Neuromethods, 37)

In Vivo Neuromethods: 32

Protocols in Molecular Neurobiology: 13 (Methods in Molecular Biology, 13)

Stimulation and Inhibition of Neurons: 78 (Neuromethods, 78)

Neuroproteomics: Methods and Protocols: 566 (Methods in Molecular Biology, 566)

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Techniques to Investigate Mitochondrial Function in Neurons: 123 (Neuromethods, 123)

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)

Neurointervention in the Medical Specialties: A Comprehensive Guide (Current Clinical Neurology)

Cellular and Molecular Methods in Neuroscience Research

Neurobiology: Methods and Protocols: 2746 (Methods in Molecular Biology, 2746)

NEUROPATHOLOGY: New Research (Neuroscience Research Progress; Neurology - Laboratory and Clinical Research Developments)